ArticleWorld journal of microbiology & biotechnology2023
Biocidal and synergistic effect of three types of biologically synthesised silver/silver chloride nanoparticles.
Article in World journal of microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Improved pleiotropic antibacterial activity of Ag(I)-Thiolate coordination polymers via iodide encapsulation in multinuclear silver nano cages.Materials today. Bio · 2025Article
- Apple Extract as an Effective Silver Reducer in the Synthesis of Ag Nanoparticles.Nanomaterials (Basel, Switzerland) · 2025Article
- Harnessing pycnidia-forming fungi for eco-friendly nanoparticle production, applications, and limitations.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Three types of silver/silver chloride nanoparticles were obtained by green synthesis from three types of microbial biomass. Their biocidal capacity was tested against six microorganisms. Two filamentous fungi were used that had previously demonstrated the ability to synthesise nanoparticles, Penicillium sp. 8L2 and Botryosphaeria rhodina MAMB-05. Also, the synthesis capacity of a yeast, Rhodotorula mucilaginosa 1S1, was evaluated. The original protocols underwent slight modifications. At the same time, the fractional inhibitory concentration was obtained. The interaction between specific antibiotics and the nanoparticles that showed the greatest biocidal capacity came from Penicillium sp.8L2, and it was studied further. All nanoparticles were characterised by UV-vis spectrophotometry and transmission electron microscopy (TEM). Also, their size distribution was analysed, which was in the range of 4 to 34 nm. The biocidal capacity of the nanoparticles for a group of bacteria and fungi was studied, presenting very low values in the range of 2.5-10 µg/mL for bacteria and 4-256 µg/mL for fungi. The interactions between the nanoparticles synthesised by Penicillium sp. 8L2 and a group of specific antibiotics for the tested microorganisms were also studied, proving that there was a synergistic interaction with vancomycin and ciprofloxacin and Staphylococcus epidermidis CECT 4183 and Escherichia coli CECT 101 bacteria, respectively.
Indexed as
Identifiers
37985512What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.